Feb 21, 2024 08:03AM
Feb 21, 2024 08:00AM
Oct 31, 2023 08:00AM
Jun 22, 2023 08:05AM
Jun 22, 2023 08:00AM
Mar 9, 2023 04:00PM
Mar 1, 2023 08:00AM aTyr Pharma (LIFE) Announces Phase 2 Study of Efzofitimod in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease
Mar 1, 2023 08:00AM
Feb 9, 2023 08:04AM
Feb 9, 2023 08:00AM
Feb 8, 2023 04:11PM
Feb 8, 2023 04:11PM
Feb 6, 2023 08:00AM
Jan 18, 2023 08:00AM European Commission Grants Orphan Drug Designation for aTyr Pharma’s Efzofitimod for Treatment of Sarcoidosis
Nov 10, 2022 04:00PM
Nov 9, 2022 08:01AM
Nov 9, 2022 08:00AM
Sep 27, 2022 08:00AM
Sep 13, 2022 08:04AM
Sep 13, 2022 08:00AM
Sep 9, 2022 08:00AM aTyr Pharma to Present at the Life Sciences Investor Forum on September 15th
Sep 9, 2022 08:00AM
Aug 15, 2022 04:00PM
Aug 11, 2022 08:03AM
Aug 11, 2022 08:03AM
May 16, 2022 08:02AM
May 16, 2022 08:00AM
May 9, 2022 04:00PM aTyr Pharma Announces First Quarter 2022 Results and Provides Corporate Update
Apr 13, 2022 08:04AM
Apr 13, 2022 08:00AM
Mar 18, 2022 06:28AM
Mar 14, 2022 04:00PM
Mar 10, 2022 08:11AM
Mar 10, 2022 08:03AM
Jan 6, 2022 08:00AM aTyr Pharma Announces FDA Orphan Drug Designation for ATYR1923 for Treatment of Sarcoidosis
Nov 30, 2021 08:00AM
Nov 10, 2021 04:00PM
Oct 6, 2021 08:00AM
Sep 13, 2021 09:39AM
Sep 13, 2021 07:30AM
Sep 13, 2021 07:30AM
Jan 5, 2021 09:30AM Pre-Open Stock Movers 01/05: (BPFH) (MRKR) (FUBO) Higher; (EGHT) (FATE) (VRAY) Lower (more...)
May 12, 2020 04:22PM
May 12, 2020 04:05PM
Apr 21, 2020 08:36AM
Apr 21, 2020 08:30AM
Nov 5, 2019 07:23AM
May 11, 2017 04:05PM
Apr 24, 2017 08:00AM aTyr Pharma Presents Analyses of Resolaris Phase 1b/2 Trial in Patients with Limb Girdle Muscular Dystrophy 2B and Facioscapulohumeral Muscular Dystrophy at the American Academy of Neurology 69th Annu
Mar 16, 2017 04:05PM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All